Behavioral Pharmacological Examination of a Novel Buprenorphine Induction Method Among Individuals Who Use Fentanyl
Conditions: Opioid Use Disorder Interventions: Drug: Naloxone Nasal Spray Sponsors: Johns Hopkins University; Cure Addiction Now Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 18, 2023 Category: Research Source Type: clinical trials
Buprenorphine Induction and Naloxone Distribution Program-Combined With Warm Hand-Off Referral to Continued Treatment
Conditions: Opioid Abuse Interventions: Behavioral: Implementation of the BINDeR-Tx service model Sponsors: Jerry Cochran; Castleview Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 18, 2023 Category: Research Source Type: clinical trials
Orexo announces data from the MODIA study evaluating impact on use of illicit opioids
UPPSALA, Sweden, Oct. 11, 2023. Orexo AB, today reports top-line results after having completed a study evaluating the efficacy of MODIA in combination with sublingual buprenorphine/ naloxone for the treatment of opioid use disorder (OUD) and... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - October 11, 2023 Category: Pharmaceuticals Source Type: clinical trials
Extended-release Buprenorphine Compared to Sublingual Buprenorphine in Rural Settings (RXR)
Conditions: Opioid-Related Disorders; Substance-Related Disorders; Narcotic-Related Disorders Interventions: Drug: Injectable extended-release buprenorphine; Drug: Sublingual buprenorphine-naloxone Sponsors: Yih-Ing Hser; National Institute on Drug Abuse (NIDA); National Institutes of Health (NIH); The Emmes Company, LLC; University of California, Los Angeles; RAND; Cornell University; Oregon Health and Science University; University of Illinois at C hicago; University of Washington; West Virginia University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 5, 2023 Category: Research Source Type: clinical trials
Low-dose Versus a High-dose Sublingual Buprenorphine Induction
Condition: Opioid Use Disorder Intervention: Drug: buprenorphine/naloxone Sponsors: Friends Research Institute, Inc.; MATClinics Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 14, 2023 Category: Research Source Type: clinical trials
